The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review

SIMPLE SUMMARY: Positron emission tomography/computed tomography (PET/CT) with prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals is a relatively novel technique currently employed in the management of prostate cancer patients. These radiopharmaceuticals target PSMA, also known...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessio, Racca, Manuela, Dall’Armellina, Sara, Rescigno, Pasquale, Banna, Giuseppe Luigi, Albano, Domenico, Dondi, Francesco, Bertagna, Francesco, Annunziata, Salvatore, Treglia, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857064/
https://www.ncbi.nlm.nih.gov/pubmed/36672305
http://dx.doi.org/10.3390/cancers15020355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857064/
https://www.ncbi.nlm.nih.gov/pubmed/36672305
http://dx.doi.org/10.3390/cancers15020355

Ejemplares similares